MEDICINOVA, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MEDICINOVA, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2021-12-31 was 0.00 shares.
- MEDICINOVA, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2021-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2021-06-30 was 0.00 shares.
- MEDICINOVA, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2021-03-31 was 1.42K shares, a 28.04% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2021 was 1.42K shares, a 62.86% decline from fiscal 2020.
- MEDICINOVA, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2020 was 3.83K shares, a 2.74% decline from fiscal 2019.
- MEDICINOVA, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2019 was 3.94K shares, a 44.43% decline from fiscal 2018.
- MEDICINOVA, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2018 was 7.09K shares, a 53.18% decline from fiscal 2017.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2021-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | 1.42K shares 10-K/A · filed 2023-03-28 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 1.42K shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 3.28K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | 1.42K shares 10-Q · filed 2021-05-13 | 3.28K shares derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | 3.83K shares 10-K · filed 2022-02-16 |
| 2020-09-30 | 1.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | 3.83K shares derived: sum of 4 quarters · filed 2020-10-26 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 3.52K shares derived: sum of 4 quarters · filed 2020-07-28 |
| 2020-03-31 | 1.98K shares 10-Q · filed 2020-04-23 | 3.52K shares derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 3.94K shares 10-K · filed 2020-02-13 |
| 2019-09-30 | 1.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | 3.94K shares derived: sum of 4 quarters · filed 2019-10-24 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | 4.63K shares derived: sum of 4 quarters · filed 2019-07-25 |
| 2019-03-31 | 2.40K shares 10-Q · filed 2019-04-25 | 4.63K shares derived: sum of 4 quarters · filed 2019-04-25 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | 7.09K shares 10-K · filed 2019-02-13 |
| 2018-09-30 | 2.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | 7.09K shares derived: sum of 4 quarters · filed 2018-10-25 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | 7.24K shares derived: sum of 4 quarters · filed 2018-07-23 |
| 2018-03-31 | 4.86K shares 10-Q · filed 2018-04-25 | 7.24K shares derived: sum of 4 quarters · filed 2018-04-25 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | 15.15K shares 10-K · filed 2018-02-13 |
| 2017-09-30 | 2.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | 15.15K shares derived: sum of 4 quarters · filed 2017-10-23 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | 18.71K shares derived: sum of 4 quarters · filed 2017-07-26 |
| 2017-03-31 | 12.78K shares 10-Q · filed 2017-04-26 | 18.71K shares derived: sum of 4 quarters · filed 2017-04-26 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | 26.65K shares 10-K · filed 2017-02-14 |
| 2016-09-30 | 5.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-25 | 26.65K shares derived: sum of 4 quarters · filed 2016-10-25 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26 | 34.29K shares derived: sum of 4 quarters · filed 2016-07-26 |
| 2016-03-31 | 20.71K shares 10-Q · filed 2016-04-27 | 34.29K shares derived: sum of 4 quarters · filed 2016-04-27 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 35.18K shares 10-K · filed 2016-02-25 |
| 2015-09-30 | 13.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | |
| 2015-03-31 | 21.60K shares 10-Q · filed 2015-05-11 | |
| 2014-12-31 | 33.37K shares 10-K · filed 2015-03-12 | |
| 2012-09-30 | 19.86K shares 10-Q · filed 2012-11-08 | |
| 2012-06-30 | 15.55K shares 10-Q · filed 2012-08-09 | |
| 2011-09-30 | 2.31K shares 10-Q · filed 2012-11-08 | |
| 2011-06-30 | 1.83K shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |